Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04115254 · ClinicalTrials.gov registry record · NA
Stereotactic Magnetic Resonance Guided Radiation Therapy
A NA study of Prostate Cancer and Lung Cancer, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 397
- Enrollment target
- 2
- Study locations
NCT04115254 is a NA study of Prostate Cancer and Lung Cancer that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 397 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (35% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04115254, a NA study of Prostate Cancer and Lung Cancer, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 397 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SMART) in patients with cancer. * The phase 1 study will evaluate the feasibility and safety of delivering SMART in patients with cancer. * Phase 2 will evaluate efficacy of SMART with specific reference to tumor control and improvement in patient reported outcome measures
Conditions Studied
Interventions
- RADIATION MR-guided Linac
Study Locations (2)
Massachusetts
- Brigham & Women's Hospital - Boston
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 397 participants |
| Start Date | 2019-10-22 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04115254
The ClinicalTrials.gov registry entry for NCT04115254 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 397 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (35% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which MR-guided Linac is the first listed.
NCT04115254 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04115254 about?
NCT04115254 is a clinical study titled "Stereotactic Magnetic Resonance Guided Radiation Therapy". This is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SMART) in patients with cancer. * The phase 1 study will evaluate the feasibility and safety of delivering SMART in patients with cancer. * Ph...
What is the current status of trial NCT04115254?
This trial is currently recruiting. It is a NA study. The enrollment target is 397 participants. The study started on 2019-10-22. Estimated completion is 2028-06.
What conditions does trial NCT04115254 study?
This clinical trial studies the following conditions: Prostate Cancer, Lung Cancer, Pancreas Cancer, Mesothelioma, Renal Cancer.
What interventions are being tested in trial NCT04115254?
The interventions under investigation include: MR-guided Linac (RADIATION).
Who is sponsoring clinical trial NCT04115254?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04115254 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.